These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 22155476
1. Neurokinin-1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression. Roche M, Kerr DM, Hunt SP, Kelly JP. Behav Brain Res; 2012 Mar 01; 228(1):91-8. PubMed ID: 22155476 [Abstract] [Full Text] [Related]
2. Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions. Burke NN, Hayes E, Calpin P, Kerr DM, Moriarty O, Finn DP, Roche M. Neuroscience; 2010 Dec 29; 171(4):1300-13. PubMed ID: 20955767 [Abstract] [Full Text] [Related]
3. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Guiard BP, Guilloux JP, Reperant C, Hunt SP, Toth M, Gardier AM. Mol Pharmacol; 2007 Dec 29; 72(6):1411-8. PubMed ID: 17890358 [Abstract] [Full Text] [Related]
4. Modulation of the CRH system by substance P/NKA in an animal model of depression. Frisch P, Bilkei-Gorzó A, Rácz I, Zimmer A. Behav Brain Res; 2010 Nov 12; 213(1):103-8. PubMed ID: 20438764 [Abstract] [Full Text] [Related]
5. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Hellweg R, Zueger M, Fink K, Hörtnagl H, Gass P. Neurobiol Dis; 2007 Jan 12; 25(1):1-7. PubMed ID: 16990008 [Abstract] [Full Text] [Related]
7. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Chourbaji S, Hellweg R, Brandis D, Zörner B, Zacher C, Lang UE, Henn FA, Hörtnagl H, Gass P. Brain Res Mol Brain Res; 2004 Feb 05; 121(1-2):28-36. PubMed ID: 14969734 [Abstract] [Full Text] [Related]
8. A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects. Herpfer I, Hunt SP, Stanford SC. Neuropharmacology; 2005 Apr 05; 48(5):706-19. PubMed ID: 15814105 [Abstract] [Full Text] [Related]
9. Adrenocortical and behavioural response to chronic restraint stress in neurokinin-1 receptor knockout mice. Delgado-Morales R, del Río E, Gómez-Román A, Bisagno V, Nadal R, de Felipe C, Armario A. Physiol Behav; 2012 Feb 01; 105(3):669-75. PubMed ID: 22019828 [Abstract] [Full Text] [Related]
10. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B, Del Rio J. Eur J Neurosci; 2007 Jan 01; 25(1):281-90. PubMed ID: 17241289 [Abstract] [Full Text] [Related]
11. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Wang D, Noda Y, Tsunekawa H, Zhou Y, Miyazaki M, Senzaki K, Nabeshima T. Behav Brain Res; 2007 Mar 28; 178(2):262-73. PubMed ID: 17261334 [Abstract] [Full Text] [Related]
12. Expression of substance P, neurokinin 1 receptors (NK1) and neurokinin 3 receptors in the developing mouse retina and in the retina of NK1 knockout mice. Catalani E, Dal Monte M, Gangitano C, Lucattelli M, Fineschi S, Bosco L, Bagnoli P, Casini G. Neuroscience; 2006 Mar 28; 138(2):487-99. PubMed ID: 16388914 [Abstract] [Full Text] [Related]
13. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease. Romano A, Pace L, Tempesta B, Lavecchia AM, Macheda T, Bedse G, Petrella A, Cifani C, Serviddio G, Vendemiale G, Gaetani S, Cassano T. Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25609597 [Abstract] [Full Text] [Related]
15. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1). Santarelli L, Gobbi G, Blier P, Hen R. J Clin Psychiatry; 2002 Apr 15; 63 Suppl 11():11-7. PubMed ID: 12562138 [Abstract] [Full Text] [Related]
16. The role of substance P in stress and anxiety responses. Ebner K, Singewald N. Amino Acids; 2006 Oct 15; 31(3):251-72. PubMed ID: 16820980 [Abstract] [Full Text] [Related]
17. [Dynamic changes of brain serotonergic and dopaminergic activities during development of anxious depression: experimental study]. Avgustinovich DF, Alekseenko OV, Bakshtanovskaia IV, Koriakina LA, Lipina TV, Tenditnik MV, Bondar' NP, Kovalenko IL, Kudriavtseva NN. Usp Fiziol Nauk; 2004 Oct 15; 35(4):19-40. PubMed ID: 15573884 [Abstract] [Full Text] [Related]
18. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice. Schulte-Herbrüggen O, Vogt MA, Hörtnagl H, Gass P, Hellweg R. Eur J Pharmacol; 2012 Feb 29; 677(1-3):77-86. PubMed ID: 22206815 [Abstract] [Full Text] [Related]
19. Neurobiology of substance P and the NK1 receptor. Mantyh PW. J Clin Psychiatry; 2002 Feb 29; 63 Suppl 11():6-10. PubMed ID: 12562137 [Abstract] [Full Text] [Related]
20. Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice. Kennedy PG, Rodgers J, Bradley B, Hunt SP, Gettinby G, Leeman SE, de Felipe C, Murray M. Brain; 2003 Jul 29; 126(Pt 7):1683-90. PubMed ID: 12805119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]